Yousef, Y.A.; Mohammad, M.; Al-Jabari, O.; Halawa, F.; Al-Fahoum, L.; Halalsheh, H.; Khzouz, J.; Al-Hussaini, M.; Jaradat, I.; Mehyar, M.;
et al. Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. Cancers 2025, 17, 1955.
https://doi.org/10.3390/cancers17121955
AMA Style
Yousef YA, Mohammad M, Al-Jabari O, Halawa F, Al-Fahoum L, Halalsheh H, Khzouz J, Al-Hussaini M, Jaradat I, Mehyar M,
et al. Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. Cancers. 2025; 17(12):1955.
https://doi.org/10.3390/cancers17121955
Chicago/Turabian Style
Yousef, Yacoub A., Mona Mohammad, Odai Al-Jabari, Farah Halawa, Lama Al-Fahoum, Hadeel Halalsheh, Jakub Khzouz, Maysa Al-Hussaini, Imad Jaradat, Mustafa Mehyar,
and et al. 2025. "Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors" Cancers 17, no. 12: 1955.
https://doi.org/10.3390/cancers17121955
APA Style
Yousef, Y. A., Mohammad, M., Al-Jabari, O., Halawa, F., Al-Fahoum, L., Halalsheh, H., Khzouz, J., Al-Hussaini, M., Jaradat, I., Mehyar, M., Rejdak, R., Toro, M. D., Haboob, H., & Al-Nawaiseh, I.
(2025). Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. Cancers, 17(12), 1955.
https://doi.org/10.3390/cancers17121955